共 50 条
Pirfenidone-Induced Sarcoid-Like Reaction A Novel Complication
被引:0
作者:
Kolaitis, Nicholas A.
[1
]
Kukreja, Jasleen
[2
]
Jones, Kirk D.
[3
]
Hays, Steven R.
[1
]
Leard, Lorriana E.
[1
]
机构:
[1] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Sch Med, Dept Surg, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Sch Med, Dept Pathol, San Francisco, CA 94143 USA
来源:
关键词:
drug toxicity;
idiopathic pulmonary fibrosis;
lung transplant;
pirfenidone (Esbrit);
sarcoid-like reaction;
IDIOPATHIC PULMONARY-FIBROSIS;
MELANOMA;
D O I:
10.1016/j.chest.2018.03.048
中图分类号:
R4 [临床医学];
学科分类号:
1002 ;
100602 ;
摘要:
Idiopathic pulmonary fibrosis is the most common idiopathic interstitial pneumonia. Prognosis is poor with a median survival <3 years. Pirfenidone is one of two US Food and Drug Administration-approved medications that slow disease progression. We describe the development of lymphadenopathy or a sarcoid-like reaction following initiation of pirfenidone, a complication not previously reported.
引用
收藏
页码:E89 / E92
页数:4
相关论文
共 50 条